BDBM50260681 4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-phenyl)-pyrazin-2-yl]-thiomorpholine 1,1-dioxide::CHEMBL496091

SMILES FC(F)(F)c1ccc(cc1)-c1ncc(nc1-c1ccncc1Cl)N1CCS(=O)(=O)CC1

InChI Key InChIKey=BXHXLZHBDIEPER-UHFFFAOYSA-N

Data  3 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50260681   

TargetCannabinoid receptor 1(Rat)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  0.830nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  0.830nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCannabinoid receptor 2(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  1.90E+3nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataIC50:  4.20nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed